Ahonen Saija, Seath Ian, Rusbridge Clare, Holt Susan, Key Gill, Wang Travis, Wang Peixiang, Minassian Berge A
1Program in Genetics and Genome Biology, The Hospital for Sick Children, 555 University Avenue, Toronto, ON M5G 1X8 Canada.
Dachshund Breed Council, Wrington, North Somerset, UK.
Canine Genet Epidemiol. 2018 Mar 27;5:2. doi: 10.1186/s40575-018-0058-8. eCollection 2018.
Canine DNA-testing has become an important tool in purebred dog breeding and many breeders use genetic testing results when planning their breeding strategies. In addition, information obtained from testing of hundreds dogs in one breed gives valuable information about the breed-wide genotype frequency of disease associated allele. Lafora disease is a late onset, recessively inherited genetic disease which is diagnosed in Miniature Wirehaired Dachshunds (MWHD). It is one of the most severe forms of canine epilepsy leading to neurodegeneration and, frequently euthanasia within a few years of diagnosis. Canine Lafora disease is caused by a dodecamer repeat expansion mutation in the gene and a DNA test is available to identify homozygous dogs at risk, carriers and dogs free of the mutation.
Blood samples were collected from 733 MWHDs worldwide, mostly of UK origin, for canine Lafora disease testing. Among the tested MWHD population 7.0% were homozygous for the mutation and at risk for Lafora disease. In addition, 234 dogs were heterozygous, indicating a carrier frequency of 31.9% in the tested population. Among the tested MWHDs, the mutant allele frequency was 0.2. In addition, data from the tested dogs over 6 years (2012-2017) indicated that the frequency of the homozygous and carrier dogs has decreased from 10.4% to 2.7% and 41.5% to 25.7%, respectively among MWHDs tested. As a consequence, the frequency of dogs free of the mutation has increased from 48.1% to 71.6%.
This study provides valuable data for the MWHD community and shows that the DNA test is a useful tool for the breeders to prevent occurrence of Lafora disease in MWHDs. DNA testing has, over 6 years, helped to decrease the frequency of carriers and dogs at risk. Additionally, the DNA test can continue to be used to slowly eradicate the disease-causing mutation in the breed. However, this should be done carefully, over time, to avoid further compromising the genetic diversity of the breed. The DNA test also provides a diagnostic tool for veterinarians if they are presented with a dog that shows clinical signs associated with canine Lafora disease.
犬类DNA检测已成为纯种犬繁殖中的一项重要工具,许多繁殖者在制定繁殖策略时会使用基因检测结果。此外,对某一品种数百只犬进行检测所获得的信息,能提供有关该品种疾病相关等位基因全品种基因型频率的宝贵信息。拉福拉病是一种迟发性隐性遗传疾病,在迷你刚毛腊肠犬(MWHD)中被诊断出来。它是犬类癫痫最严重的形式之一,会导致神经退行性变,并且在诊断后的几年内常常需要实施安乐死。犬类拉福拉病由该基因中的十二聚体重复序列扩增突变引起,有一项DNA检测可用于识别有风险的纯合犬、携带者以及无该突变的犬。
从全球733只MWHD中采集血样用于犬类拉福拉病检测,这些犬大多来自英国。在检测的MWHD群体中,7.0%为该突变的纯合子,有患拉福拉病的风险。此外,有234只犬为杂合子,表明在检测群体中携带者频率为31.9%。在检测的MWHD中,突变等位基因频率为0.2。此外,对6年多(2012 - 2017年)检测犬的数据表明,在检测的MWHD中,纯合子犬和携带者犬的频率分别从10.4%降至2.7%,从41.5%降至25.7%。因此,无该突变犬的频率从48.1%增至71.6%。
本研究为MWHD群体提供了有价值的数据,并表明DNA检测是繁殖者预防MWHD发生拉福拉病的有用工具。在6年多的时间里,DNA检测有助于降低携带者和有风险犬的频率。此外,DNA检测可继续用于逐步消除该品种中的致病突变。然而,这应该随着时间的推移谨慎进行,以避免进一步损害该品种的遗传多样性。如果兽医遇到表现出与犬类拉福拉病相关临床症状的犬只,DNA检测也为他们提供了一种诊断工具。